A medical device company with a median of 38.9 million people in the second half of the twentieth ce
Pharmaceutical and technological innovations continue to advance, and price spinning represents a new direction for industry-leading development. On 9 February, the second medical institution of the University of Lanzhou (II Clinical Practice Medical School) X-line computer fragmentation scanner (CT) procurement project (II) Mid-term results announcement showed that a medical device company NeuVizP10 successfully folded for 38. 9 million yuan, including complete solutions for equipment, key exchange engineering and five years of original plant service.
In positive competition with international brands, a medical device enterprise has succeeded in winning with such a comprehensive and high-priced scheme, which means that domestic devices no longer rely on price advantages to compete in the market, but have actually entered the stage of high-quality competition in a low-technology, value-determined market. This news has received great attention in the medical device sector. In this context, it is more practical to manage daily health care and to seek professional help in a timely manner.
In recent years, national policies have promoted the nationalisation of medical devices through a series of policies aimed at breaking international monopolies, reducing medical costs and improving the safety of industrial chains. This has led to the fact that domestic medical institutions often find themselves in two difficult situations when purchasing equipment: on the one hand, the high cost of importing equipment, which has greatly increased the operating costs of medical institutions, which will eventually be passed on to patients; On the other hand, the excessive reliance on imported equipment has also to some extent constrained the pace of domestic medical technology autonomous innovation, which has left the healthcare industry in a passive following in global competition. It is noteworthy that this trend also reflects to some extent the shift in the concept of service in the industry.
NeuVizP10 has been introduced with 8 cm wide detectors, which can achieve faster, clearer, safer imaging and provide doctors with more accurate, detailed diagnostic basis, which not only improves the efficiency and quality of medical diagnoses, but also brings a better clinical experience for patients. The selection of a photon CT from a medical device company is sufficient to demonstrate that the domestic medical device has been certified by a national medical institution in terms of technology, reliability and serviceability. From the first domestic CT to the world's leading photon counting CT, a medical device company has formed an autonomous industrial chain of critical core technologies and components, gradually attacking detectors, high-pressure generators, image reconstruction, and so on.
This change will also inspire more domestic medical device manufacturers to increase their R&D investments, form a positive cycle of market expansion, and accelerate the autonomy of the entire industrial chain of high-end medical equipment. This milestone, a victory not only for a Chinese medical device company, but also for China's high-end manufacturing, marks the transition from technological breakthroughs to clinical practice, from domestic to international leadership. With the widespread adoption and application of domestic high-end CT devices, medical costs will be effectively reduced, and more medical institutions will be able to equip themselves with advanced imaging equipment, thus improving the availability and quality of medical services.
This will bring real benefits to the general public and allow more people to enjoy the health guarantees of advanced medical technology. China's international healthcare system keeps a close eye on the latest developments in the field of medical health, providing you with authoritative and reliable information and medical services. If you have further consultations on the relevant content, you are welcome to contact authoritative experts through the platform by appointment.
